You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

DAUNORUBICIN HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for daunorubicin hydrochloride and what is the scope of patent protection?

Daunorubicin hydrochloride is the generic ingredient in two branded drugs marketed by Hikma, Sanofi Aventis Us, Wyeth Ayerst, Fresenius Kabi Usa, Hisun Pharm Hangzhou, Meitheal, and Teva Parenteral, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for daunorubicin hydrochloride. Two suppliers are listed for this compound.

Summary for DAUNORUBICIN HYDROCHLORIDE
US Patents:0
Tradenames:2
Applicants:7
NDAs:10
Drug Master File Entries: 9
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 68
Clinical Trials: 374
Patent Applications: 7,347
What excipients (inactive ingredients) are in DAUNORUBICIN HYDROCHLORIDE?DAUNORUBICIN HYDROCHLORIDE excipients list
DailyMed Link:DAUNORUBICIN HYDROCHLORIDE at DailyMed
Recent Clinical Trials for DAUNORUBICIN HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Phase 3
Gilead SciencesPhase 2
Uwe PlatzbeckerPhase 2

See all DAUNORUBICIN HYDROCHLORIDE clinical trials

Pharmacology for DAUNORUBICIN HYDROCHLORIDE

US Patents and Regulatory Information for DAUNORUBICIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hisun Pharm Hangzhou DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 208759-001 Apr 12, 2019 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma CERUBIDINE daunorubicin hydrochloride INJECTABLE;INJECTION 064103-001 Feb 3, 1995 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Parenteral DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 064212-002 May 3, 1999 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 065000-001 May 25, 1999 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 065034-001 Nov 20, 2001 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Meitheal DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 065035-001 Jan 24, 2000 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.